(335c) Antifouling Zwitterionic Hydrogel Coating Improves Hemocompatibilityof Activated Carbon Hemoadsorbent

Li, Q., Tianjin Univerisity
Zhang, L., Tianjin University
Cai, N., Tianjin Univerisity
Activated carbon has been widely used in hemoperfusion treatments, an adsorption-based technology which can be used to remove toxic substances from the blood of patients suffering from severe intoxications, nephritic, hepatic/multiorgan insufficiency, autoimmune diseases, sepsis, etc. However, the performance of activated carbon has been significantly compromised by their poor hemocompatibility: firstly, upon contacting with blood, they suffer from non-specific blood protein adsorption which would cover the adsorbents’ surface and significantly reduce their adsorption ability; secondly, activated carbon materials would result in serious clinical side effects such as particulate microemboli formation, hemolysis and blood coagulation. In this work, we developed a novel anti-biofouling adsorbent based on zwitterionic poly-carboxybetaine (PCB) hydrogel and powdered activated carbon (PAC) to improve hemocompatibility. We found this new adsorbent (PCB-PAC) was highly stable with negligible leakage of activated carbon debris. It could efficiently resist protein adsorption and avoid any hemolysis effect. The large mesh size of the PCB hydrogels allowed efficient mass transfer of the adsorbates, and was superior to PEGMA or PHEMA hydrogels which were commonly used. The adsorption performance of PCB-PAC for methylene blue was not influenced in a single protein solution or even in 100% fetal bovine serum (FBS), in which pristine PAC lost 50% of its adsorption ability. The isotherms results showed that the adsorption process of PCB-PAC fitted the Langmuir isotherm well, indicating that the PAC particles were homogenously distributed in the PCB hydrogel matrix. Moreover, PCB-PAC could also adsorb bilirubin molecules bound to albumin in solution, while pristine PAC showed no discernible adsorption effect. Findings in this work hold great potential to significantly improve the performance and efficiency of current extracorporeal devices for removing toxins from blood directly.


This paper has an Extended Abstract file available; you must purchase the conference proceedings to access it.


Do you already own this?



AIChE Members $150.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $225.00